Please login to the form below

Not currently logged in
Email:
Password:

Onyx Pharma appoints John Osborn SVP global corporate affairs

Joins from Dendreon to lead public and government affairs activities

Dendreon's John Osborn has joined Onyx Pharmaceuticals as senior VP, global corporate affairs.

In his new role at the US-based biopharma, he will lead the company's public and government affairs activities, as well as key stakeholder relationships.

Osborn's most recent position was executive VP, general counsel and secretary at Dendreon, which markets cancer vaccine Provenge.

Prior to his time at Dendreon, he held similar roles at US Oncology and Cephalon.

He also spent time serving with the US Department of State and was a member of the bipartisan United States Advisory Commission on Public Diplomacy in 2008.

“As a lawyer, policy advocate and former diplomat, John brings a diverse and extensive background to Onyx, with broad experience across the life sciences industry and the US government,” said Dr Anthony Coles, president and CEO of Onyx.

“John is a proven leader and his unique expertise aligns well with our plan for global growth as a multi-product company reaching patients around the world.”

20th July 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

The new pharma marketing playbook
Learn about the 5 areas that must be in your pharma marketing playbook...
Pharma needs to evolve from customer-centricity to stakeholder-centricity
Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders....
5 health behavioural factors to incorporate in your marketing
Achieve real health behaviour change by including these elements in your pharmaceutical marketing....

Infographics